# Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)

> **NCT01849770** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 75 (actual)

## Conditions studied

- Sporadic Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Mexiletine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01849770
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01849770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01849770, "Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01849770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*